Favorable Clinical Outcomes with Valacyclovir for Cytomegalovirus Prophylaxis Following Allogeneic Hematopoietic Cell Transplantation

Authors

Amir Toor MD, Lehigh Valley Health NetworkFollow

Publication/Presentation Date

3-2020

Volume

26

Issue

3

Published In/Presented At

10.1016/j.bbmt.2019.12.314

Disciplines

Medicine and Health Sciences

Department(s)

Department of Medicine, Lehigh Valley Topper Cancer Institute

Document Type

Article